Demographic Analysis of Cancer Research Priorities and Treatment Correlations

Overview

Journal Curr Oncol

Publisher MDPI

Specialty Oncology

Date 2024 Apr 26

PMID 38668042

Authors

Denis Horgan

Marc Van Den Bulcke

Umberto Malapelle

Nicola Normanno

Ettore D Capoluongo

Arsela Prelaj

Carmelo Rizzari

Aliki Stathopoulou

Jaya Singh

Marta Kozaric

France Dube

Manuel Ottaviano

Stefania Boccia

Gabriella Pravettoni

Ivana Cattaneo

Nuria Malats

Reinhard Buettner

Karim Lekadir

Francesco De Lorenzo

Catherine Alix-Panabieres

Sara Badreh

Eric Solary

Ruggero De Maria

Paul Hofman

Affiliations

Soon will be listed here.

Abstract

Understanding the diversity in cancer research priorities and the correlations among different treatment modalities is essential to address the evolving landscape of oncology. This study, conducted in collaboration with the European Cancer Patient Coalition (ECPC) and Childhood Cancer International-Europe (CCI-E) as part of the "UNCAN.eu" initiative, analyzed data from a comprehensive survey to explore the complex interplay of demographics, time since cancer diagnosis, and types of treatments received. Demographic analysis revealed intriguing trends, highlighting the importance of tailoring cancer research efforts to specific age groups and genders. Individuals aged 45-69 exhibited highly aligned research priorities, emphasizing the need to address the unique concerns of middle-aged and older populations. In contrast, patients over 70 years demonstrated a divergence in research priorities, underscoring the importance of recognising the distinct needs of older individuals in cancer research. The analysis of correlations among different types of cancer treatments underscored the multidisciplinary approach to cancer care, with surgery, radiotherapy, chemotherapy, precision therapy, and biological therapies playing integral roles. These findings support the need for personalized and combined treatment strategies to achieve optimal outcomes. In conclusion, this study provides valuable insights into the complexity of cancer research priorities and treatment correlations in a European context. It emphasizes the importance of a multifaceted, patient-centred approach to cancer research and treatment, highlighting the need for ongoing support, adaptation, and collaboration to address the ever-changing landscape of oncology.

References

Braz I, Gomes R, Azevedo M, Alves F, Seabra D, Lima F . Analysis of cancer perception by elderly people. Einstein (Sao Paulo). 2018; 16(2):eAO4155. PMC: 6019243. DOI: 10.1590/S1679-45082018AO4155. View

Thompson S, Nedkoff L, Katzenellenbogen J, Hussain M, Sanfilippo F . Challenges in Managing Acute Cardiovascular Diseases and Follow Up Care in Rural Areas: A Narrative Review. Int J Environ Res Public Health. 2019; 16(24). PMC: 6950682. DOI: 10.3390/ijerph16245126. View

Brtnikova M, Studts J, Robertson E, Dickinson L, Carroll J, Krist A . Priorities for improvement across cancer and non-cancer related preventive services among rural and non-rural clinicians. BMC Prim Care. 2022; 23(1):231. PMC: 9462636. DOI: 10.1186/s12875-022-01845-1. View

Estape T . Cancer in the Elderly: Challenges and Barriers. Asia Pac J Oncol Nurs. 2018; 5(1):40-42. PMC: 5763438. DOI: 10.4103/apjon.apjon_52_17. View

van de Haar J, Hoes L, Coles C, Seamon K, Frohling S, Jager D . Caring for patients with cancer in the COVID-19 era. Nat Med. 2020; 26(5):665-671. DOI: 10.1038/s41591-020-0874-8. View

Taberna M, Gil Moncayo F, Jane-Salas E, Antonio M, Arribas L, Vilajosana E . The Multidisciplinary Team (MDT) Approach and Quality of Care. Front Oncol. 2020; 10:85. PMC: 7100151. DOI: 10.3389/fonc.2020.00085. View

Graetz D . The most vulnerable pediatric cancer patients. Lancet Reg Health Am. 2023; 21:100480. PMC: 10064219. DOI: 10.1016/j.lana.2023.100480. View

Krzyszczyk P, Acevedo A, Davidoff E, Timmins L, Marrero-Berrios I, Patel M . The growing role of precision and personalized medicine for cancer treatment. Technology (Singap World Sci). 2019; 6(3-4):79-100. PMC: 6352312. DOI: 10.1142/S2339547818300020. View

Uyl-de Groot C, Heine R, Krol M, Verweij J . Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe. Cancers (Basel). 2020; 12(8). PMC: 7464890. DOI: 10.3390/cancers12082313. View

10.

Groot B, Haveman A, Buree M, Zuijlen R, Zuijlen J, Abma T . What Patients Prioritize for Research to Improve Their Lives and How Their Priorities Get Dismissed again. Int J Environ Res Public Health. 2022; 19(4). PMC: 8871903. DOI: 10.3390/ijerph19041927. View

11.

Seghers P, Wiersma A, Festen S, Stegmann M, Soubeyran P, Rostoft S . Patient Preferences for Treatment Outcomes in Oncology with a Focus on the Older Patient-A Systematic Review. Cancers (Basel). 2022; 14(5). PMC: 8909757. DOI: 10.3390/cancers14051147. View

12.

Thomas G, Eisenhauer E, Bristow R, Grau C, Hurkmans C, Ost P . The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report. Eur J Cancer. 2020; 131:76-88. DOI: 10.1016/j.ejca.2020.02.050. View

13.

Agarwal S . Pediatric Cancers: Insights and Novel Therapeutic Approaches. Cancers (Basel). 2023; 15(14). PMC: 10377340. DOI: 10.3390/cancers15143537. View

14.

Mendonca E Silva D, Fernandes G, Silva I, Curado M . Cancer stage and time from cancer diagnosis to first treatment during the COVID-19 pandemic. Semin Oncol. 2023; 50(1-2):60-65. PMC: 10030331. DOI: 10.1053/j.seminoncol.2023.03.005. View

15.

Manafo E, Petermann L, Vandall-Walker V, Mason-Lai P . Patient and public engagement in priority setting: A systematic rapid review of the literature. PLoS One. 2018; 13(3):e0193579. PMC: 5834195. DOI: 10.1371/journal.pone.0193579. View

16.

Soerjomataram I, Bray F . Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nat Rev Clin Oncol. 2021; 18(10):663-672. DOI: 10.1038/s41571-021-00514-z. View

17.

Post H, Schutte T, van Oijen M, van Laarhoven H, Hollak C . Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries. ESMO Open. 2023; 8(2):101208. PMC: 10163159. DOI: 10.1016/j.esmoop.2023.101208. View

18.

Greenhalgh T, Hinton L, Finlay T, Macfarlane A, Fahy N, Clyde B . Frameworks for supporting patient and public involvement in research: Systematic review and co-design pilot. Health Expect. 2019; 22(4):785-801. PMC: 6737756. DOI: 10.1111/hex.12888. View

19.

Glasgow R, Brtnikova M, Dickinson L, Carroll J, Studts J . Implementation strategies preferred by primary care clinicians to facilitate cancer prevention and control activities. J Behav Med. 2023; 46(5):821-836. PMC: 10098247. DOI: 10.1007/s10865-023-00400-2. View

20.

Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J . The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. 2022; 613(7942):130-137. DOI: 10.1038/s41586-022-05522-2. View